Icsh recommendations for the measurement of haemoglobin f
International Journal of Laboratory Hematology
The Official journal of the International Society for Laboratory Hematology
I N T E R NATI O N A L J O U R NA L O F L A B OR ATO RY H E M ATO LO G Y
ICSH recommendations for the measurement of Haemoglobin F
A. D. STEPHENS*, M. ANGASTINIOTIS†, E. BAYSAL‡, V. CHAN§, B. DAVIS–, S. FUCHAROEN**,P. C. GIORDANO††, J. D. HOYER‡‡, A. MOSCA§§, B. WILD–– ON BEHALF OF THE INTERNATIONALCOUNCIL FOR THE STANDARDISATION OF HAEMATOLOGY (ICSH)
College London Hospitals, London, UK†Thalassaemia International Federation
Measurement of the Haemoglobin F in red cell haemolysates is
important in the diagnosis of db thalassaemia, hereditary persis-
tence of fetal haemoglobin (HPFH) and in the diagnosis and man-
ticsCentre,AlWasiHospital,Dubai,UAE§Department of Medicine, The
agement of sickle cell disease. The distribution of Hb F in red cells
is useful in the diagnosis of HPFH and in the assessment of feto-
maternal haemorrhage. The methods of quantifying Hb F are
described together with pitfalls in undertaking these laboratory
tests with particular emphasis on automated high-performance
liquid chromatography and capillary electrophoresis.
Mahidol University, Thailand††Hemoglobinopathies ReferenceLaboratory, Human and ClinicalGenetics Department, LeidenUniversity Medical Center, Leiden, TheNetherlands‡‡Division of Hematopathology, TheMayo Clinic College of Medicine,Rochester, MN, USA§§Dipartimento di Scienze e TecnologieBiomediche, Universita` degli Studi diMilano, Italy––UK NEQAS(H), Watford, UK
Correspondence:Dr A. D. Stephens, Department ofHaematology, University College LondonHospitals, 250 Euston Road, LondonNW1 2PJ, UK. Tel.: 020 344 79638;Fax: 020 344 79911;E-mail: adrian.stephens@mac.com
Received 13 April 2011; accepted forpublication 13 June 2011
KeywordsHaemoglobin F, high-performanceliquid chromatography, capillaryelectrophoresis, recommendedmethods, haemoglobinopathy,thalassaemia
Ó 2011 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem.
assessment of the proportion of red cells of fetal originis clinically useful in assessing the amount of FMH that
It is now 30 years since the first ICSH recommenda-
has occurred and the medication to be given. Assessing
tions were published (International Committee for
the proportion of cells that contain a high proportion of
Standardization in Haematology, 1979) concerning the
fetal haemoglobin (often called F cells) is also useful in
quantification of Haemoglobin F (Hb F); and during
the diagnosis of ‘classical’ deletional HPFH.
this time, there have been several new analytical devel-opments in the field, and therefore the ICSH Boardconsider that the original recommendations should be
revised. Hb F is a haemoglobin tetramer composed of
In 1866, it was noted that fetal haemoglobin is more
two a and two c globin chains (a2c2). It is a normal
resistant to alkali than adult haemoglobin (von Kor-
haemoglobin and is the major haemoglobin present in
ber), but it was not until 1951 (Singer, Chernoff &
the fetus but is gradually replaced after birth by Hb A
Singer, 1951) that this property was utilized to measure
(a2b2) as the c chains are replaced by b chains. The
the amount of fetal haemoglobin present in red cell
measurement of Hb F in red cells is clinically useful in
haemolysates (the one-minute alkali denaturation
the diagnosis of db thalassaemia because the amount of
technique). This technique was refined by in 1959
Hb F is raised in this condition. Hb F is also slightly
(Betke, Marti & Schlicht, 1959) when they published
raised (1–5%) in pregnancy (Pembrey, Weatherall &
their two-minute alkali denaturation technique and
Clegg, 1973), in hereditary persistence of fetal haemo-
this was further modified in 1972 (Pembrey, Mcwade &
globin (HPFH) and sometimes in b thalassaemia trait. It
Weatherall, 1972). This two-minute alkali denaturation
is occasionally raised in other situations (Table 1), but
technique has been considered to give accurate and
apart from sickle cell disease and feto-maternal haem-
clinically useful results in the 0–40% range of Hb F but
orrhage (FMH), there is little clinical utility in measur-
to underestimate the amount of Hb F at higher levels;
ing the Hb F in these other situations (Mosca et al.,
although in clinical situations, this is not a problem.
2009). The clinical effects of sickle cell disease can be
This method was selected by the ICSH as the recom-
reduced by using drugs such as hydroxyurea (hydroxy-
mended method for clinical use (International Com-
carbamide) which raise the Hb F level and measuring
mittee for Standardization in Haematology, 1979), and
the Hb F level can then be clinically useful in helping
in the same article, a method was described for prepar-
ing a standard for Hb F. The method for producing a HbF standard was further modified by Wild (1986) to pro-
Table 1. Conditions in which Hb F is raised
duce the 1st WHO International Reference Material forHb F (World Health Organization Expert Committee on
Biological Standardization, 1994) for use with the two-
minute alkali denaturation method. This is a stabilized,
freeze-dried cyanmethaemoglobin preparation pre-
pared from blood obtained from the father of a patient
with beta thalassaemia major and is held at National
Institute of Biological Standards and Controls (NIBSC)
Hereditary persistence of fetal haemoglobinSickle cell anaemia ± treatment with
In 1958, column chromatography of haemolysates
from human blood showed that fetal haemoglobin
could be separated from adult haemoglobin and that a
small proportion of the fetal haemoglobin separated
from the main Hb F peak (Allen, Schroeder & Balog,
1958), and it was later shown that this small peak
was acetylated Hb F (Schroeder et al., 1962). Becausethe acetylated Hb F eluted before the main peak, it
was called FI and the main peak FII, but the main
Ó 2011 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem.
peak was later renamed Fo when the main peak of
may mislead analysts into believing that the accuracy
adult haemoglobin was renamed Ao. It was later
is also good. It is important that the sample loading is
shown that these two types of fetal haemoglobin
within the manufacturer’s recommended range as not
could also be separated by isoelectric focusing (Basset
only must the column not be overloaded, but it is
et al., 1978). Automated, dedicated high-performance
essential that the optical absorbance is kept within the
liquid chromatography (HPLC) was introduced in the
linear range because if too much sample is applied
late 1980s to simplify and speed up screening of
any large peaks may be underestimated leading to a
maternal blood samples for Hb A2, Hb F and common
relative overestimation of small peaks such as the Hb
haemoglobin variants (such as Hb S, C, D, E and O).
F. It is equally important that the baseline used for
Recently, automated capillary zone electrophoresis
the integration is correct as only those parts of the
(CZE) has been introduced as an alternative to auto-
peak that are above the baseline will be quantified,
mated HPLC for screening blood samples for Hb A2,
and this may lead to parts of a peak being excluded
Hb F and the common variant haemoglobins (Van
from the integration if the baseline is incorrectly
Delft et al., 2009). The c-chains of Hb F may contain
assigned. As a general rule, with the equipment used
either glycine or alanine at position 136 (cG and cA)
for quantifying Hb F, the baseline should be straight
because of the presence of two c genes (cG and cA)
and close to the horizontal. Ideally, the baseline
coding for almost identical products, but these two
should be obtained by running a blank sample twice
forms do not separate on HPLC or CZE, but at the
(so that there is no haemoglobin present) at the
present time, there is no clinical advantage in measur-
beginning of each batch and recording the chromato-
ing the cG & cA chains separately. A radial immuno-
gram produced with the second blank (to avoid any
diffusion technique has also been developed and is
carry over), and this should be used as the baseline
commercially available. With the huge increase in
for that batch of samples. If a haemoglobin peak (such
throughput of Hb A2 and Hb F measurements in
as Hb H) elutes with the void volume and if as occurs
hospital laboratories because of both the mandatory
with some systems, the integration excludes the ‘void
and the voluntary screening programmes, automated
peak’; then, in the presence of Hb H, the total amount
HPLC or CZE have become the main tool to quantify
of haemoglobin will be underestimated leading to an
Hb F and Hb A2 in most laboratories in Europe and
overestimation of the Hb F peak. Accurate quantifica-
North America and is being increasingly used in Asia
tion of a peak also requires that that peak is com-
and Africa, and capillary isoelectric focusing (cIEF) is
pletely separated from neighbouring peaks, and this is
also being introduced. However, dedicated instru-
especially important for small peaks such as Hb F. For
ments are available from different companies, and
all these reasons, it is extremely important that the
these approach the analytical issues in different ways.
chromatogram, or electropherogram, is inspected care-
When it is necessary to assess the proportion of red
fully before the results are authorized. Because Hb F is
cells that are of fetal origin either a cytochemical tech-
reported as a ratio of Hb F to the total haemoglobin, as
nique such as the Kleihauer method (Kleihauer,
long as there is an appropriate baseline associated with
Braun & Betke, 1957; Kleihauer, 1974) or the
good peak integration, area calibrators should not be
Shepard modification of it (Shepard, Weatherall &
necessary as they are a poor substitute for inadequate
Conley, 1962) or flow cytometry can be used (Nelson
chromatography or peak quantification. However,
et al., 1998; Leers et al., 2007). These techniques can
standards and controls remain essential to verify that
also be used to study cases of HPFH.
the equipment is working satisfactorily. Although forHPLC and capillary isoelectric focusing it is the peakareas that are related to the amount of haemoglobin
present, it should be noted that in CZE the peak areas
With automated systems such as HPLC, CZE and cIEF,
should not be used for quantification because of the
the accuracy of peak quantification is dependent on
different migration velocities through the detector,
both the peak resolution and the method of peak inte-
instead the ‘spatial area’ (integrated area divided by
gration. Poor peak quantification will result in poor
the migration time) should be used (Huang, Coleman
accuracy but may still result in good precision that
& Zare, 1989; Hempe & Craver, 1999).
Ó 2011 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem.
S A M P L E C O L L E C T I O N A N D S T O R A G E
cut-off in adults, this is not a problem. Nevertheless,CVs of the order of 2–3% can be obtained at higher
Any anticoagulant can be used although it is common
Hb F concentrations (Papadea & Cate, 1996; Paleari
to use K2EDTA which is the anticoagulant used for
et al., 2005). Accuracy is harder to establish and moni-
the analysis of blood counts. Ideally, the analysis
tor but comparison with National or Regional quality
should be undertaken as soon as possible after vene-
assessment schemes can be helpful. A WHO reference
section, but storage of a sealed whole blood sample at
material is available, but it was only analysed by the
4 °C for 2–3 weeks is acceptable as there will be mini-
two-minute alkali denaturation technique.
mal oxidation at 4 °C during that time (Tietz, 1990). Where there are high ambient temperatures, such asin tropical areas, suitable means of transport must be
H I G H - P E R F O R M A N C E L I Q U I D
used to prevent deterioration because considerable
denaturation of haemoglobin occurs if a sample is
Several companies now produce dedicated HPLC sys-
kept at 50 °C for more than 1 h. Sample stability after
tems (Van Delft et al., 2009). These are all similar in
freezing at )20 °C or at )80 °C is not well docu-
that they all utilize a weak cation-exchange column in
mented, although some manufacturers claim an over-
their instruments. A sample of RBC lysate is injected
all stability of 1 month at )20 °C and 3 months at
into the system; haemoglobin molecules will attach to
)80 °C. When freezing samples, it is essential that the
the column as they are charged molecules in the buffer
blood samples are frozen as quickly as possible
system used. An eluting solution is then injected into
because slow freezing of proteins promotes denatur-
the system; the composition of this solution changes by
ation; one satisfactory way is to freeze drops of whole
increasing the ionic strength. The haemoglobin frac-
blood or haemolysate in liquid nitrogen. Thawing and
tions (normal plus any haemoglobin variant) will elute
re-freezing of blood samples should be discouraged. A
off the column when the ionic strength of the eluting
partially coagulated blood sample should not be
solution is greater than the retention to the column.
accepted for Hb F quantification by automated equip-
Different haemoglobin variants will have different
ment as it may contaminate or block the tubing.
overall charges because of the amino acid substitutionthat is present. Thus, the time at which the haemoglo-
bin molecule elutes off the column (retention time) ischaracteristic and reproducible, but not unique, for
To be clinically useful, the results of the Hb F quantifi-
each haemoglobin variant. As the haemoglobin frac-
cation have to be expressed as a percentage of the total
tions elute off the column, they pass through a detec-
haemoglobin (which will usually include Hb A, Hb F,
tion system which utilizes absorbance readings at 415
Hb A2 and any glycated, acetylated or aged adducts).
and 690 nm. The percentage of each haemoglobin frac-tion (Hb A, Hb F, Hb A2, and any variant) is calculatedby summing the area under the curve of each peak of
the chromatogram. Glycated haemoglobins, such as Hb
As stated earlier, both precision and accuracy are
AIc, and methaemoglobin elute from the column as
extremely important because a raised level of Hb F
separate peaks distinct from and before Hb A as does
may be indicative of the diagnosis of HPFH or delta
the ‘aged peak’ AId. Fast variants, such as Hb H or Hb
beta thalassaemia trait. The precision obtainable in the
Barts, may not be quantified as they may elute off the
manual techniques is ±0.1% in the final answer that is
column before the instrument begins to integrate
equivalent to an SD of 0.05% (leading to a CV of 5%
in many systems designed for adult samples, and this
in the normal range and better when raised as often
will affect the quantification of Hb F. However, they
occurs in thalassaemia). A similar precision should be
are usually quantified in systems designed for neonatal
obtainable in modern automated HPLC and capillary
samples that start integrating sooner.
electrophoretic equipment and is sufficient for diag-
nostic purposes. Some HPLC systems are not able to
sufficient accuracy for clinical purposes as long as the
detect Hb F below 1% but because 1% is the normal
Hb F peak is adequately separated from the other
Ó 2011 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem.
peaks and from any variant haemoglobins present.
sures the absorbance at 415 nm. An electropherogram
Because the FI peak is only a very small proportion of
(similar to a chromatogram) is thus generated; the per-
the total Hb F, it is only apparent on neonatal
centage of each haemoglobin fraction (Hb A, Hb F, Hb
samples, or adult samples with fairly large amounts of
A2, plus any haemoglobin variants) is calculated (but
Hb F. If an alpha globin variant is present that
see the paragraph aforementioned on peak integration
separates from Hb A, then there will be a Hb F variant
because ‘spatial areas’ have to be used for quantifica-
that will often separate from normal Hb F but it may
tion because of the different velocities of peaks past
not separate from the other haemoglobin adducts
the detector). For haemoglobinopathy, work CZE has
present and then the total Hb F will not be adequately
the same advantages as HPLC over manual methods
quantified. Hb F variants may also be due to muta-
but some equipment and reagents have an advantage
tions in the c globin chain, and again this may result
over HPLC in that haemoglobin adducts such as glycat-
in a separate peak and incorrect quantification. Some
ed XIa,b,c and the ageing glutathione adduct, XId, do
b-chain variants and/or their adducts will not separate
not separate from the main haemoglobin peaks, and
from Hb F, and this will also lead to incorrect quanti-
this makes interpretation easier than with HPLC.
fication. In the absence of a haemoglobin variant, theHb F separates from Hb A, its glycated adducts and
C A P I L L A R Y I S O E L E C T R I C F O C U S S I N G
the Hb A2, and therefore its quantification should besatisfactory. The presence of any haemoglobin variant
In cIEF, the electro-osmotic flow is minimized by coat-
eluting before Hb Ao on HPLC will frequently lead to
ing the inside of the capillary with a solution to neu-
inaccurate quantification. In these situations, a differ-
tralize the silanols. The capillary is filled with a
ent technique such as the two-minute alkali denatur-
mixture of ampholytes and haemolysate. After applica-
ation method will give a clinically useful result.
tion of the voltage for a period of time, the haemoglo-bins become focussed at their pI value. They are thenmobilized and pass through the detector operating at
C A P I L L A R Y Z O N E E L E C T R O P H O R E S I S
415 nm (Hempe & Craver, 1999), and an electrophero-
This method utilizes a thin capillary made of fused
gram (similar to a chromatogram) is thus generated;
silica with an outer coating of polyimide and usually
the percentage of each haemoglobin fraction (Hb A, Hb
with an inner diameter of 50 or 75 lm. Because the
F, Hb A2, plus any haemoglobin variants) is calculated.
capillary has a very large surface to volume ratio, it isexcellent at dissipating the heat generated by the
C Y T O C H E M I C A L T E C H N I Q U E
applied voltage. Thus, very large voltages (10–30 kV)can be used and because of these high voltages, the
For semi-quantitative estimation of the distribution of fetal
run times are significantly shortened and the resolu-
Hb in the red cell population. A blood smear is prepared
tion increased. The inner surface of the capillary tube
on glass slide, fixed in 80% ethanol and then immersed
has a negative charge because of the bare silica. When
for 5 min at 37 °C in citrate-phosphate buffer pH 3.3
an electric field is applied, the buffer solution within
(citric acid 0.075 M and disodium phosphate 0.05 M). The
the capillary generates an electro-endosmotic flow
elution time and pH of the buffer have to be carefully con-
(EOF) that moves towards the cathode. A sample of
trolled (Shepard, Weatherall & Conley, 1962; Kleihauer,
haemolysate is injected into the system, and the
1974). In patients with deletional HPFH, all RBCs show
electric current applied causes separation of individual
almost uniform retention of haemoglobin (pancellular
haemoglobins because of differences in overall charges.
distribution), whereas in b thalassaemia trait with
Haemoglobin variants, if present, separate because of a
increased Hb F, and nondeletional HPFH, a hetero-
charge difference resulting from the amino acid substi-
cellular distribution of haemoglobin occurs.
tution. However, regardless of the overall charge ofeach haemoglobin fraction, the EOF is still stronger
than any attraction to either pole, and all haemoglobinfractions will move towards the cathode. All the hae-
Flow cytometric assay can be used to assess the
moglobin molecules move past a detector which mea-
number and distribution of ‘F cells’ in the blood.
Ó 2011 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem.
Adult F cells are erythrocytes where the haemoglobin
commercially with associated standards covering the
is represented by a mixture of Hb A and Hb F (Wood
et al., 1975). All individuals have some F cellsestimated at an average of 2.7% of cells in normal
I N T E R P R E T A T I O N O F R A I S E D L E V E L S
adults by an earlier nonflow cytometric fluorescei-
nated antibody technique (Davis et al., 1998). Flowcytometric techniques suggest that this level may be
At birth, the average level of Hb F is around 80% but
even higher in normal individuals (Chen, Bigelow &
depends on the age of gestation. After birth, the Hb F
Davis, 2000). F cells can be more prevalent in anaemia
steadily decreases to reach adult levels (<1%) during
and in some haemoglobinopathies. The enumeration of
the second year of life. In thalassaemia trait levels of
‘light pink’-staining F cells vs. ‘deep red’-staining fetal
up to 10% may be recorded depending on the muta-
cells by the traditional Kleihauer slide test may be
tion and the haplotype. In db thalassaemia trait levels
difficult (CLSI, 2001). Quantification of F cells may be
from 5% to 20% are found. In HPFH heterozygotes,
helpful in the management of patients with sickle cell
Hb F levels from 2.5% in the ‘Swiss’ type and to up to
disease treated with hydroxyurea and also when
30% in the deletional forms are found. In homozygous
monitoring patients with myelodysplasia. However,
deletional HPFH and in homozygous nontransfused bo
measurement of the total Hb F in a haemolysate by
thalassaemia major, the Hb F level will be 100%. Ery-
HPLC or CZE is usually easier and clinically just as use-
thropoetic stress and malignancies may induce variable
ful. Commercial assays have been developed for under-
As is the case with all clinical assays, the use of
internal quality control is important. Controls cannotonly be used to assess the quality of Kleihauer staining
It is important to be able to quantify Hb F for the
but are also used to better define the region of analysis
diagnosis of db thalassaemia and HPFH and in sickle
positive for fetal cells in flow cytometry. Controls can
cell disease at diagnosis, and whilst monitoring the
be made locally in the laboratory, using artificial mix-
effect of hydroxycarbamide (hydroxyurea) in sickle
tures of fresh cord blood and adult blood samples, or a
cell disease or b thalassaemia major or intermedia.
commercial preassayed product can be used. Quality
The accuracy and precision of Hb F quantification in
performance of the FMH or fetal red cell detection
blood samples with Hb F levels in, or very close to,
assays are described in the CLSI H52-A document
the normal range is often poor, but this is rarely a
(CLSI, 2001). This lists potential problems with the
diagnostic problem. Hb F levels of 2–3% calculated in
Kleihauer and flow cytometry methods.
HPLC areas crowded with glycated fractions should becritically examined for overestimation. Assessment ofthe cellular distribution is useful in the diagnosis of
T W O - M I N U T E A L K A L I D E N A T U R A T I O N
HPFH and when investigating suspected FMH. Meth-
ods used in clinical laboratories first involve separating
If a manual technique is required, the two-minute
the Hb F from Hb A and Hb A2 and from any
alkali denaturation method (Betke, Marti & Schlicht,
other haemoglobin present and then quantifying the
1959) as modified by Pembrey, Mcwade and Weather-
different fractions and calculating the proportions of
all (1972) is still a useful way of assessing the Hb F
the different haemoglobins because it is the propor-
concentration in clinical situations but has the disad-
tion, not the absolute amount, of Hb F that is clini-
vantage that it is time consuming and requires experi-
cally important. Historical methods of analysis. The
two-minute alkali denaturation technique (Pembrey,Mcwade & Weatherall, 1972; International Committeefor Standardization in Haematology, 1979) which
R A D I A L I M M U N O D I F F U S I O N T E C H N I Q U E
were discussed in a previous publication can produce
Haemoglobin F can be quantified by radial immuno-
results that are satisfactory for most clinical purposes
diffusion. Plates containing anti-Hb F are available
but are time consuming and need experience to
Ó 2011 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem.
obtain good results. Automated HPLC with dedicated
cially available capillaries and buffers are becoming
available and can also produce satisfactory results if
increasingly being introduced and can give satisfactory
no haemoglobin variant is present, but considerable
results if no haemoglobin variant is present, but
experience is necessary to interpret the electro-
considerable experience is necessary to interpret the
pherogram. At present, the only internationally recog-
chromatograms. If any haemoglobin variants are
nized standard for Hb F is the WHO 1st Reference
present, the analysis may lead to misleading results. It
Material (85/616) that is available from NIBSC,
is essential that the reagents are optimized for Hb F
Blanche Lane, South Mimms, Potters Bar, Hertford-
rather than Hb AIc and that the baseline is appropri-
shire EN6 3QG, UK (http://www.nibsc.ac.uk), but it
was only analysed by the two-minute alkali denatur-
automated capillary isoelectric focusing with commer-
fetal haemoglobin reference preparations and
denaturation. Journal of Clinical Pathology
fetal haemoglobin determination by the alkali
Allen D.W., Schroeder W.A. & Balog J. (1958)
denaturation method. British Journal of Hae-
Pembrey M.E., Weatherall D.J. & Clegg J.B.
Observations on the chromatographic hetero-
(1973) Maternal synthesis of Haemoglobin F
Kleihauer E. (1974) Determination of fetal
in pregnancy. Lancet 1, 1350–1355.
hemoglobin: a study of the effects of crystalli-
zation and chromatography on the heteroge-
Detection of Hemoglobinopathies (eds R.M.
neity and isoleucine content. Journal of the
Schmidt, T.H.J. Huisman & H. Lehmann),
acetyl-containing hemoglobin. Biochimica et
American Chemical Society 80, 1628–1634.
20–22. CRC Press, Cleveland, Ohio.
Basset P., Beuzard Y., Garel M.C. & Rosa J.
Kleihauer E., Braun H. & Betke K. (1957). cited
Shepard M., Weatherall D. & Conley C. (1962)
(1978) Isoelectric focusing of human hemo-
Semi-quantitative estimation of the distribu-
globin: its application to screening, to the
von Korber E. (1866). cited by Singer K, Cher-
tion of fetal hemoglobin in red cell popula-
characterization of 70 variants, and to the
tions. Bulletin of the Johns Hopkins Hospital
study of modified fractions of normal hemo-
Leers M.P., Pelikan H.M., Salemans T.H., Giord-
ano P.C. & Scharnhorst V. (2007) Discrimi-
Singer K., Chernoff A.I. & Singer L. (1951)
Betke K., Marti H.R. & Schlicht L. (1959) Esti-
Studies on abnormal haemoglobins: 1. Their
mation of small percentage of fetal haemoglo-
Chen J.C., Bigelow N. & Davis B.H. (2000) Pro-
of alkali denaturation. Blood 6, 413–428.
posed flow cytometric reference method for
Reproductive Biology 134, 127–129.
Tietz N., Finley P.R. & Pruden E.L. (1990) Clini-
the determination of erythroid F-cell counts.
Mosca A., Paleari R., Leone D. & Ivaldi G.
cal Guide to Laboratory Tests. 2nd edn W.B.
(2009) The relevance of hemoglobin F mea-
surement in the diagnosis of thalassemias and
Van Delft P., Lenters E., Bakker-Verweij M., De
Korte M., Baylan U., Harteveld C.L. & Giord-
ano P.C. (2009) Evaluating five dedicated
Davis B.H., Olsen S., Bigelow N.C. & Chen J.C.
Nelson M., Zarkos K., Popp H. & Gibson J. (1998)
(1998) Detection of fetal red cells in fetoma-
A flow-cytometric equivalent of the Kleihauer
diagnostics in multi-ethnic populations. Inter-
ternal hemorrhage using a fetal hemoglobin
national Journal of Laboratory Hematology
Paleari R., Cannata M., Leto F., Maggio A.,
Demartis F.R., Desogus M.F., Galanello R. &
Wild B.J. (1986). The development of reference
Hempe J.M. & Craver R.D. (1999) Laboratory
Mosca A. (2005) Analytical evaluation of the
materials for Hb A2 and Hb F. PhD, Brunel.
diagnosis of structural hemoglobinopathies
Wood W.G., Stamatoyannopoulos G., Lim G. &
and Thalssemias by capillary isoelectric focus-
for hemoglobin A2 and F determination.
Nute P.E. (1975) F-cells in the adult: normal
ing. In: Clinical Applications of Capillary
Clinical Biochemistry 38, 159–165.
values and levels in individuals with heredi-
Electrophoresis (ed. S.M. Palfrey), 81–98.
Papadea C. & Cate J.C.T. (1996) Identification
tary and acquired elevations of Hb F. Blood
and quantification of hemoglobins A, F, S,
Huang X., Coleman W.F. & Zare R.N. (1989)
and C by automated chromatography. Clini-
World Health Organization Expert Committee
Analysis of factors causing peak broadening
on Biological Standardization (1994). Biologi-
in capillary zone electrophoresis. Journal of
Pembrey M.E., Mcwade P. & Weatherall D.J.
(1972) Reliable routine estimation of small
WHO Technical Report Series – 848. World
International Committee for Standardization in
Ó 2011 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem.
HIGHLIGHTS OF PRESCRIBING INFORMATION Treatment is repeated daily for five days. This five-day treatment course may These highlights do not include all the information needed to use Fusilev be repeated at 4 week (28-day) intervals, for 2 courses and then repeated at 4 safely and effectively. See full prescribing information for Fusilev. to 5 week (28 to 35 day) intervals provided tha